Smoking is... good?

  • Thread starter Thread starter morgan
  • Start date Start date
Smoking and 4D STS

Telperion said:
However...if nicotine has it's benefits we need to find/spread info about a better way to get it than from cigarettes which have a lot of other toxic chemicals....
Apparently there is "pure" tobacco available for those willing to roll their own (others on this forum know more about that than I, and can provide further info; I'm not a smoker myself).

It appears that there are some people who derive more "benefit" from nicotine than others, no doubt due to their chemical make-up -- just as some people with chemical imbalances derive benefit from anti-depressant medications. But, obviously, that does not automatically translate into "Everyone should smoke and/or take anti-depressants." Some may need to, most probably do not.

I've known people for whom quitting was an absolutely hellish experience, and who inevitably "relapsed" because of the extreme mood swings that resulted -- or who simply adopted another, often more harmful addiction to help even out their moods, such as alcohol, drugs, or over-eating. For such people quitting brings no real "benefit". I've also known individuals who found it relatively easy to quit; who also experienced lots of "negative" emotions, like anger, sadness, frustration, etc., as a result. But for them their lives improved as a result of quitting, because they saw the smoking as an addiction that served to "mask" emotions that they did not want to face/deal with, and therefore, for them, giving up cigarettes resulted in personal growth, and more of a sense of wholeness.

So it's different for different people, and for some it clearly has something to do with some kind of chemical imbalance, which nicotine remedies. And if the scientific/medical establishment were more open to that possibility, they might discover a less physically harmful substitute that would serve the same function. But until then, some people just need to smoke....
 
Smoking and 4D STS

yup there's yet another article that laura put together in which everything pretty much is summed up , here it is..lets all light up! , it is very very interesting article which exposes a lot of what u r saying , also we have the C's that said on one occasion this :
[...]
Q: (L) Is smoking detrimental to any of our bodies?
A: Not if mild. Not if mind is in right mode.
Q: (L) Does smoking enhance psychic abilities?
A: Yes.
Q: (L) Is it true that the government program to stamp out smoking is inspired by the Lizzies?
A: Yes because they know it may heighten psychic abilities.
Q: (L) What is causing the lung cancer they are attributing to smoking?
A: Mental conditioning and subliminal programming to expect it.
Q: (L) So, it only happens if you are convinced that it can and must happen?
A: Correct.
Q: (L) Is there any particular brand of cigarettes to smoke?
A: No.
[...]
so there u have it......
 
I found the following passage in a book by a polish doctor Jan Kwasniewski (Homo optimus) on smoking, that I found interesting:

Smoking tobacco has a different effect in different individuals. Depending on the number of smoked cigarettes and on the diet content, smoking can accelerate atherosclerosis, it can have no effect, or it can actually retard the development of the disease. Of course, it does not follow, that the smoking of cigarettes is recommended. But before giving any advice to anyone, the whole truth should be known. Smoking more than 40 cigarettes (paralysis of the sympathetic system) will accelerate atherosclerosis in the heart or the brain arteries, whereas smoking 10 - 15 a day (stimulation of the sympathetic system) will theoretically act against it. In those suffering from diseases which are classified as anti-atherosclerotic syndromes, the dominance of the sympathetic system occurs. A low number of smoked cigarettes will intensify this dominance, thus, accelerate the progress of disease, but atherosclerosis will not be accelerated, in particular atherosclerosis of the brain and the coronary arteries.
 
Clinic offers stop-smoking regimen that scares doctors

Yet another stumbled upon product that can be marketed as a stop smoking aid... even if it has that common annoying little side effect of making you want to take your life. How many mood elevators and emotion controlling drugs are they going to make that generate suicidal tendencies?

Antismoking Pill May Ease Depression ... Or Cause Suicidal Thoughts
By Aaron Rowe

Two drugs that act on nicotine receptors are now being tested as antidepressants -- offering hope to the millions of people who don't respond to traditional antidepressants.

Chantix, a pill that can help people quit smoking, and Inversine, a hypertension drug, appear to exert a soothing effect by blocking nicotine receptors in the brain. There's just one catch: Chantix may also exacerbate suicidal tendencies.

Chantix came on the market in 2006 and has recently been blamed for causing suicidal thoughts, prompting the FDA to issue not one, but two, advisories about the drug. That came after friends and family of Dallas musician Carter Albrecht blamed Chantix for the erratic behavior that led to his violent death. Quite a few smokers described worrisome emotional side effects on blogs and in the pages of New York Magazine.

But after Brown psychiatry resident Noah Philip gave one of his chronically downcast patients a prescription for Chantix to help break her smoking habit, he got an unexpected surprise. During their first follow-up appointment, she was smiling and felt great. When he learned that his colleagues had similar experiences, the young doctor knew that he was on to something.

To follow up on his revelation, Philip and his mentor Lawrence Price are conducting a study to test the mood-elevating effects of the medication. At Butler Hospital in Providence, Rhode Island they are giving depressed smokers Chantix in addition to their regular psychiatric medications. Over the course of eight weeks, Philip and Price will monitor the volunteers and pay close attention to their ability to enjoy life as well as unwanted side effects.

"At this point we haven't had any adverse events similar to those reported, but several people have become irritable," says Philip.

A 2006 study published in the New England Journal of Medicine revealed that half of all patients do not respond to conventional antidepressants, so new strategies to fight the disease are desperately needed.

Created by a team at Pfizer, Chantix can suck the pleasure out of smoking by blocking nicotinic acetylcholine receptors -- neurological buttons that are usually pushed by tobacco products. Lightly stimulating those same proteins, the medication also creates a sensation similar to but weaker than the one created by tobacco products, which can cut down on withdrawal symptoms.

One thing is certain: The drug does not have an antidepressant effect for everyone. Since it may elevate the mood of some and causes intense feelings of sadness in others, a lab test that could predict how patients will respond to the pill would be invaluable. But until scientists understand the subtle biological variations that cause some people to feel miserable and others to have the opposite experience, that sort of personalized medicine will remain in the realm of science fiction.

"It would be very interesting to study what might be different about the patients who are reporting that they feel less depressed on Chantix," says Marina Picciotto, a professor of psychiatry at Yale University who studies nicotinic acetylcholine receptors. "It will also be interesting to see whether there is any difference in antidepressant response to Chantix between smokers and nonsmokers."

Scientists are confident that the simple act of kicking a nicotine addiction is not the underlying cause of the amazing mood improvements.

"Quitting smoking does not seem to help depression," says Tony George, a professor at the University of Toronto. "There is no evidence that nicotine or smoking causes depression. They seem to be behaviors that have common genetic roots."

George has tested the antidepressant-assisting effects of the blood pressure drug Inversine (mecamylamine), which blocks nicotinic receptors, but does not gently stimulate them like Chantix. Aside from saying that the combination seems to work on people who are unresponsive to traditional antidepressants alone, the addiction expert is not comfortable sharing his results until they are published.

George points out that studies have not confirmed the antidepressant qualities of Chantix, although he is cautiously optimistic. "I think there is lots of evidence to speculate that such a mechanism might be therapeutic in depression, at least as an adjunct to standard antidepressant treatments," George says.

http://www.wired.com/medtech/drugs/news/2008/03/chantix

There is this bit of objective science.

At Butler Hospital in Providence, Rhode Island they are giving depressed smokers Chantix in addition to their regular psychiatric medications.

Pray tell, how can you get any sort of valid clinical observations about a drug's effect by adding it to other drugs already in the subject's system? Those pesky control studies just take too much time, I guess... and the FDA doesn't care these days.

Last edited by Rabelais (2008-03-19 17:22:35)
 
Smoking and 4D STS

flashgordonv said:
Recent events have led me to try to pull together a number of threads into a new (for me) working hypothesis on why there is such pressure for people to stop smoking. Let me provide some background and also try to lay out the different threads I am trying to pull together.

....

2. I did some study some time ago with a gentlemen who was working in the field of brain function. He had a lot to say about emotions and chemicals, repeating some of the work done by Candice Pert. One of the really interesting things he had to say was that the whole process of neurotransmitter attaching to receptor had two parts to it. Not only was the neurotransmitter keyed so that it and only it could fir the receptor, like a special key, but also there was a vibration involved, again specific to the transmitter and the receptor. An here is the kicker, he showed us some research out of Europe where they same effect was achieved by playing the appropriate vibration across the receptor, in the complete absence of the chemical neurotransmitter. In other words, it is possible for emotions to be stimulated in us by the use of the appropriate vibration on us. ( I am painfully conscious that I have not documented any of this yet, so before anybody challenges me for promoting hearsay allow me to say that I am currently at work, my books are at home, and I will try to provide the appropriate source documents in the next 24 hours)
OK, it took me a little longer than 24 hours but the author I was referring to is Bruce Lipton PhD and the book is called 'The Biology of Belief". A quick synopsis follows: "a groundbreaking work on cell biology and quantum physics written by former research scientist Dr Bruce Lipton. [....] As a result of his research, Lipton concludes cells, genes and DNA do not control our biology. it is the energy that passes through and interacts with these elements that determine how they function. DNA is controlled by signals from outside the cell, including the energetic messages emanating from our positive and negative thoughts. Lipton confirms that from a scientific standpoint, the mind has the power to control our biological health. ...."
 
Second-hand smoking study jumps to conclusions....

At work today I was linked to a study that discusses the deleterious effects of second hand smoke. The article is on the web here: Brief secondhand smoke exposure can cause blood vessel and stem cell damage in 30 minutes (_http://healthorbit.ca/NewsDetail.asp?opt=1&nltid=158290408). It's full of scary phrases and innuendo like;

a 30-minute exposure to the level of secondhand smoke that one might normally inhale in an average bar setting was enough to result in blood vessel injury in young and otherwise healthy lifelong nonsmokers. Compounding the injury to the blood vessels themselves, the exposure to smoke impedes the function of the body’s natural repair mechanisms that are activated in the face of the blood vessels’ injury...
That's basically the thesis of the paper. I was a bit skeptical so I went onto science direct and got a pdf copy of the research to check out for myself. There were a few problems that I saw with the logic and argument presented, and to think that this study is used to make such drastic declarations as those above is very disturbing to say the least.

My first problem with the study, is the sample size (n=10). So they based their conclusions off of a extremely small group of the population. The sample was weighed towards males (7 men 3 women) and they were all approximately 30 years old. No discrimination was made for race, and it would have been nice to have racial data, since race has been known to influence how well or not one tolerates substances. Beyond that, of the ten participants, none had been exposed to second hand smoke, nor had every smoked cigarettes before in their life. We're not told if they were recently exposed to a fire, or if they smoked anything besides cigarettes. My guess is they were negative for both accounts, but still, for a scientific paper these things need to be controlled, accounted for, and discussed.

The first line of the study reads, "Exposure to secondhand smoke (SHS) accounts for about 50,000 deaths annually in the United States, mostly from heart disease." That basically sets the tone for the rest of the paper, an idea known as priming.

Continuing on with the Methods, smokers were categorically excluded from the study. Later, we're told that one of the effects (levels of Epithelial Progenitor Cells, EPCs) is decreased in 'chronic smokers', in contrast to the data here which shows increased EPCs in the sample group. I would have been interested to see a much larger sample set, including smokers.

The cigerattes used in the study were Marlboro Reds, which any smoker can tell you, are not your average cigarette. This brings up another point I often have with the smoking issue. There is a world of difference between processed, chemical laden cigarettes and those that are additive free with organically grown tobacco. This study makes no distinction, according to them all second-hand smoke is qualitatively equivalent. I won't harp on them too much though, as they were trying to simulate bar-like conditions, and SHS will contain a random sampling from every brand under the sun.

One thing the study pointed out was the concentration of particulate matter vs nicotine (367ug/m3 vs 67ug/m3, respectively). I would have been interested in a chemical analysis of the 'particulate matter', I'm sure it's been done, including as a reference it would have been a nice addition, especially considering some of the other works referenced.

They also measured Endothelium-dependent dilation of the brachial artery (flow-mediated dilation, FMD):
Baseline data for diameter and blood flow velocity of the brachial artery were quantified after 10 min of supine rest in a 21 Degree C room. A forearm blood pressure (BP) cuff was placed distal to the antecubitcal fossa and inflated to 250mm Hg for 5 min. Diameter was measured immediately after cuff deflation, at 20s, 40s, 60s, & 80s. The FMD was expressed as: (DiameterMAX - DiameterBASELINE)/DiameterBASELINE.
This method seemed a bit odd to me, mostly because they don't tell us whether or not the same was repeated to get their data post-exposure to SHS. I would hope that the same methodology was repeated in each instance, as they collected data points at 0h (30min after exposure), 1h, 2.5h & 24h. As the paper stands, we simply do not know.

We're shown their baseline cotinine levels (a metabolite of nicotine), are approximately 0.8ng/ml. This caught my attention because cotinine is a biomarker for second hand smoke, and yet it does occur naturally within the body. This opens up a new line of questioning, such as - What else causes cotinine levels to rise and fall? What is it's natural function within the body?

The way they measured 'vascular damage' was indirect, and I thought this point needed to be emphasized as it was categorically ignored in the article linked above. Their results demonstrated an increased number of EPCs, elevated level of plasma VEGF (vascular endothelial growth factor), increased systolic blood-pressure and increased EMP generation. They cite studies that demonstrate these items to be indicative of vascular damage.

They also performed ex vivo (done outside the body with biological material) experiments to determine EPC motility, and I had a slight issue here as they're drawing conclusions in vivo for processes they measured ex vivo (a small point). This is where their data comes to conclude that the repair mechanisms are 'dysfunctional' or 'impaired', along with the FMD data - which as I mentioned above, were gathered with questionable methodology.

Throughout their discussion I was confronted with phrases like, "our results suggest" "may also affect" "seems to be independent" "may be relevant" "suggest" "potentially" "which may lead to" "has been associated" "our results imply". Those nine alone came from a single paragraph. To give context, this is the type of conjecture associated with the 'discussion' section of a scientific paper, but it seems a bit overabundant. We do have to recall that the sample size was ten nonsmokers and the cigarette used was a marlboro red. These two factors alone discourage this type of conjecture. They also make this admission,
Several controversies exist regarding the nature and potential biological effects of circulating EMPs, and there is no consensus on the method for their identification. The phenotype of circulating microparticles varies depending on the cellular origin and the release mode which may subsequently determine their biological functions.
Yet the authors go on, in the very next sentence to proclaim:

The initial decrease in FMD in our study was paralleled by significantly increased numbers of EMPs in plasma, suggesting that even short exposure to SHS causes acute vascular injury/endothelial and structural damage.
They do go on to correlate their findings with those that demonstrate the same in heart disease patients, those suffering from renal disease & diabetes. However, considering that 'several controversies exist' and 'there is no consensus for their identification' their conclusions seem a bit of a stretch.

Overall the paper was not terribly difficult to read, nor was the terminology unclear - that is one complaint I typically have with proteomics papers. The biggest problem with the paper is the extremely small sample size, even my experiments have tissue coming from 30+ different individuals, and good papers that have human subjects always have at least 20-50 if not 100-1000 different people participating. This gives validity to the data and the conclusions, with such a small sample size we cannot say much for certain, and it seems the authors and those writing about the paper are saying a lot as if it is for certain.

Beyond that my complaints are more superficial, no racial data, some methodology was unclear, and many of their conclusions are drawn from indirect (though supported by parallel research) ways at measuring 'vascular damage'. I do remind the reader that the cigarette used was a marlboro red, and further, that there are hundreds of chemicals added to cigarettes and the paper to yield various affects. What role these chemicals play in the effects seen above we do not know, and this point is completely ignored by the authors of the paper as well as the author of the article. This is disingenuous when drawing conclusions about 'smoking', 'tobacco' and 'nicotine'.

If I were to perform the same study I would use a much larger sample size, n=100, ensure racial diversity and equivalent numbers of men and women within the same age group. I would also perform the experiment once for non-smokers, & once for smokers. Further, I would compare the effects between those inhaling second hand smoke from a mainstream cigarette, (Marlboro, Camel, Newport) and a cigarette containing only 100% natural, organic tobacco with no additives in the tobac or the rolling paper. The conclusions drawn from such a study would much more educational, informative, and valid then those previously presented.

Paper: Brief Secondhand Smoke Exposure Depresses Endothelial Progenitor Cells Activity and Endothelial Function. Christian Heiss, Nicolas Amabile, Andrew Lee, Yerem Yeghiazarians, et al.
UCSF, Journal of the American College of Cardiology, May 2008.
 
Second-hand smoking study jumps to conclusions....

A few problems and questions:
====================
1. Does the sample cover wide population diversity?
+ Caucasian
+ Blacks
+ Native American
+ European
+ and on and on...
2. What constitutes a good/bad sample?
+ Where is the racial diversity data? (See above)
+ Where is the age groups data coverage?
+ 0.1-10
+ 11-20
+ 21-30
+ 31-40
+ 51-60
+ 61-70
+ 71-80
+ 81-91
+ 100+
+ What do we know of each sample's state before and after testing:
+ General health conditions: before and after
+ Cancer, history: before and after
+ Anything else we should know about?
+ DNA markers: what changes, if any noted?
+ Blood:
+ type: what changes, if any noted?
+ diseases/cures: what changes, if any noted?
+ and on and on...
+ What about any BENEFITS before and after?
+ List and breakdown BENEFITS here...

These are but a very limited dataset. It ought to cover all known cases
to create (good and/or bad) data for which `smoking' might beneficial or
damaging.

Perhaps the researchers are looking for (negative-only/manipulated) data
to fit their agenda? Now, where did I hear that before? :D

The devil is in the details.
 
Study shows smoking lowers risk for rare breast cancer

http://www.cnn.com/HEALTH/9805/19/smoking.breast.cancer/index.html

This article is ten years old. Interesting headline.

WASHINGTON (CNN) -- Researchers said they were surprised and even embarrassed to find that smoking cigarettes apparently reduces the risk of breast cancer among women with an unusual gene mutation.

Researchers caution that the study does not mean women should smoke.

"The risks of smoking are so serious that there's absolutely no reason that any woman should consider smoking whether she is at high risk or low risk for breast cancer," said Dr. Lynn Schuchter, an oncologist at the University of Pennsylvania Cancer Center.
Smokers had half as many cancers

The study is being published in the Journal of the National Cancer Institute. The authors were trying to find out what lifestyle factors might influence cancer development in women with a mutated gene called BRCA-1 or BRCA-2. By some estimates, about 80 percent of such women will develop breast cancer during their lifetime. One in 250 women have the mutated gene.
Lab testing
Doctors are hoping this discovery leads to new treatment strategies

The researchers were surprised by the results.

"We found that among women who carried a mutation in one of these genes, cigarette smoking did have an effect in reducing their risk of developing breast cancer," said Dr. Caryn Lerman of the Lombardi Cancer Center.

The incidence of breast cancer among study participants who smoked heavily was 54 percent lower than among the non-smokers. The study found the more the women smoked, the less likely they were to get breast cancer.
Estrogen's role

The researchers said cigarettes are probably protecting these women because some compound in cigarettes interferes with the use of estrogen, a hormone already linked to breast cancer.

Doctors hope their research will lead to the development of new medications that reduce breast cancer risk without the deadly effects of smoking.

Smoking still sharply increases the incidence of other cancers, including deadly lung cancer.

"We are embarrassed because we feel that the tobacco industry may propagate this without being responsible," said Gilbert Lenoir, a biologist who worked on the study.
 
Study shows smoking lowers risk for rare breast cancer

Odd couldn't find the paper referenced through my usual channels. If anyone gets a copy I'd love to take a look.
 
Study shows smoking lowers risk for rare breast cancer

I wonder if this is the one you mean?
http://jnci.oxfordjournals.org/cgi/content/abstract/90/10/761
http://jnci.oxfordjournals.org/cgi/reprint/90/10/761

It says the full text PDF version is free.
 
Nicotine and autism treatment

I found this interesting article while wondering if there is a link between the recent anti-smoking campaigns (among other agendas) and the incredible growing rate of autism. Because autistic people cling to ideas so dearly, do not question them and will even defend them to the point of violence (in my experience anyway of having an autistic brother), autism seems to be a very valuable tool to the PTB to 'produce' these people, and as many as possible. Here is what I found;
Joan Arehart-Treichel
Cholinergic nicotinic receptors, which have become a hot area for brain researchers, are linked to yet another psychiatric-neurological disorder—autism.

Deep inside the human brain, cholinergic nicotinic receptors are busy plying their trade, and one might view them as triple agents. They release the nerve transmitter acetylcholine from certain nerve ends, they receive it at others, and they can be stimulated by nicotine—yes, from cigarette smoking!

Even more intriguing, these receptors have been implicated of late in a spate of psychiatric and neurological disorders such as Alzheimer’s disease, Parkinson’s disease, schizophrenia, and Tourette syndrome (Psychiatric News, March 13, 2000).

And now the receptors have been linked to yet another psychiatric-neurological condition—autism.

The finding comes from Elaine Perry, Ph.D., of Newcastle General Hospital in Newcastle-Upon-Tyne, England, and her colleagues. It is reported in the July American Journal of Psychiatry.

"This is an important paper," Peter Whitehouse, M.D., Ph.D., a neurologist-psychologist with Case Western Reserve University in Cleveland, told Psychiatric News. "It is probably the first [neurochemical] investigation of cholinergic systems in autism. And the findings regarding the nicotinic receptors do suggest a potential role for them in the mechanisms of autism, particularly related to the ability to focus attention and to interact with other people."

During the past few years, there have been intimations that the nerves and other brain mechanics that concern themselves with acetylcholine—the so-called "cholinergic systems"—might be implicated in autism. For example, cholinergic neurons in the basal forebrain, an area of the brain known to be involved in attention, have been found to be abnormally plentiful, and abnormally large, in children with autism.

As for a chemical known to influence the development and function of cholinergic neurons in the basal forebrain area—brain-derived neurotrophic factor—abnormally high levels of it have been found in the bloodstreams of newborns with autism. Thus, these and some other discoveries prompted Perry and her team to try to determine whether, and how, various cholinergic players conspire in the autism disease process.

They acquired frozen brain samples from seven deceased adults who had had autism and from 10 deceased adults who had no mental disorder. They then examined the activities of specific cholinergic functions in the brain samples and compared the activity of each function in brain samples from the autistic subjects with the activity in brain samples from the control subjects.

If any functions were found to behave abnormally in brain samples from autistic subjects, they reasoned, then those functions might well be culprits in the autism disease process.

For instance, the researchers measured in the brain samples the activity of acetylcholinesterase, the enzyme that makes acetylcholine. They then compared the activity of the enzyme in samples from the autism group with the activity of the enzyme in samples from the control group. They found no difference. So they concluded that this particular enzyme is probably not implicated in autism.

They also measured the activity of the enzyme that breaks down acetylcholine. They then compared the activity of this enzyme in samples from the autism group with the activity of this enzyme in samples from the control group. Again they found no difference. So they concluded that this enzyme, too, is not involved in autism.

However, they did find something interesting regarding the chemical that is known to influence the development and function of cholinergic neurons in the basal forebrain—that is, brain-derived neurotrophic factor.

They found three times more of the factor in the basal forebrain area of brain samples taken from autism subjects than in samples taken from mentally normal subjects. So they think that this factor might indeed be involved in autism.

And they also found considerably less nicotinic receptor activity in the cerebral cortex of brain samples taken from autism subjects than in the cerebral cortex of samples taken from mentally normal subjects. So they believe that faulty nicotinic receptors might also be culprits in autism.

Such findings, they concluded in their paper, suggest that "the role of the cholinergic system in autism should be investigated further. . . ."

Also of interest, they wrote, is that the abnormalities they have detected in brain samples from autism subjects more closely resemble those in brain samples from schizophrenia subjects than those in brain samples from Alzheimer’s disease or Parkinson’s disease subjects. Such similarities, they believe, are not surprising since "there is an extensive overlap in clinical symptoms between autism and schizophrenia, both behaviorally and cognitively. . .and the same neural systems are likely to be involved in both, although differing in developmental staging and etiology."

But the findings by Perry and her team are especially provocative because they may point the way to an effective treatment for autism—something that does not currently exist. For instance, might nicotine or another drug that stimulates the nicotinic receptors possibly help autism patients? Perry thinks so. In fact, she told Psychiatric News, she would like to explore this possibility. The most recently approved drug for Alzheimer’s disease—galantamine—might also be able to counter autism, Whitehouse conjectures. The reason, he said, is that the drug is thought to be capable of influencing the nicotinic receptors (Psychiatric News, April 20).
This research also might suggest that people who have eaten a heavily gluten/casein/soy/msg laden diet for most of their lives (these foods are what have been shown to cause autism) could repair the damage with the help of nicotine.
 
Nicotine and autism treatment

My, my, my...

It's funny how, at the beginning, it sounds like they are saying that nicotine is implicated in causing the problems, but what is really going on is that smoking HELPS people with Parkinson's, Alzheimer's, and Autism. But you don't figure that out until the end.

Yeah, smoking increases acetylcholine receptors! I reported on this when I was writing the Wave back in 99.

The anti-smoking thing has been going on in a serious way since the 80s, I think, and I heard recently that the death rate from things they were attributing to smoking is continuing to go up. They lamely try to say "must be smoking" all the while forgetting that smoking rates have gone down, so they are hoisted on their own petard.
 
Nicotine and autism treatment

I began to smoke 2006, It was because I found the idea very interesting and did read as much research I could related to it, then when I was sure/satisfied there were beneficial effects from the nicotine I began to smoke. I have been as aware as I can about the changes mentally and physically, I find it have had a few noticeable changes, my wight dropped to a ideal weight (about 4-6kg that I could not loose even when going to the gym and running +walking)
My mind feel clearer, I don't get as distracted when thinking about a problem or a concept. What I mean with that is before I started smoking I tented to be quite distracted but that have subsided.
I don't smoke much, about 1-2 small cigar a day.

Montecristo-Mini-Cigarillos-Box-Of-50.jpg


edit: I forgot to add that I have not been sick when people around be have been ill by flu and other viruses, don't know if that is related cuz I seldom get sick but It have not been negative immune effects in either case :)
 
Nicotine and autism treatment

So what do you suppose should be done in the treatment of children with autism? Is there actually any harm that is caused to the developing brain as a result of nicotine as so many people would have you think? Now that I think about it, is the idea that smoking under the age of 18 a complete sham? If nicotine does boost mental performance so much, wouldn't smoking (or getting nicotine some other way [for children]) help develop the brain opposed to hindering it? I may be going off the conspiracy theory 'deep-end' with this (lol), but could this be the reason that smoking is only legal to those 18+? Letting children think much more effectively would be exactly opposite to the intentions of the PTB; to brain wash and 'dumb-down' people in school. Especially since nowadays all the school children are subject to a huge aount of wi-fi, cell phone and who-knows-what radiation. But what's a parent to do? Even if this is an effective approach, the fact that it would be extremely looked down upon (to give your autistic child any form of nicotine) by society, would stop a good percentage of the population. Ill have to do some digging.
 
Nicotine and autism treatment

While I was searching on google, I found two links that (in the description below the link) looked very promising. But when I tried to read them, I got a "page not found" screen (funny, aye?). It wasn't until I came along a teen/adolescence anti-smoking site that I came along something interesting;
Because previous studies have shown adolescence to be a particularly vulnerable period for exposure to cigarettes, Koob and his team at Scripps studied nicotine withdrawal in adolescent and adult rats. He expected to find that teen rats were more sensitive to the negative effects of nicotine, but found the opposite of what he expected— they were less sensitive to them. "The teenage rats don't show withdrawal to nicotine. They don't show a physical withdrawal syndrome, which is measured by small autonomic-type signs, small measurable things that a rat will do— their eyes will go smaller...they'll sometimes shake their head...they'll show increased irritability— during nicotine withdrawal. The young animals don't show those effects, as if they're not affected by nicotine withdrawal."
Koob says there have also been studies "showing that young animals actually will self-administer more nicotine, not less nicotine, and show bigger arousal effects from nicotine." So not only does nicotine seem to be less repellant for teens, it also appears to be more rewarding. "Whatever nicotine does initially to the organism, it has less of the negative effects in adolescents and in teenagers, and more of the positive effects," says Koob. "And as a result, it's much easier for teenagers to smoke more and more."
Of course, this is shown to make the argument that it is easier for teens to get addicted to nicotine since they don't feel any negative effects or have any withdrawl symptoms. And the extra "because previous studies have shown adolescence to be a particularly vulnerable period for exposure to cigarettes" is nice to remind us that, yes, cigarettes are indeed bad for them.
Another interesting post I found on another anti-smoking site is;
According to recent human and animal research, adolescents are more susceptible to developing nicotine dependence than adults, because a single drug exposure can lead to lasting neuronal changes associated with learning and memory (Fagen Mansfelder, Keath, & McGehee, 2003). The earlier the exposure to nicotine, the greater is the impact on the neuronal circuity of the still developing brain causing irreversible effects on hippocampal structure, function, learning and memory (Slotkin, 2002).
Then I looked up the effects of nicotine on hippocampal structure, function, learning and memory. Most of which is in Laura's literature, except I don't recall a reference to the "hippocampal structure" (if so I apologize). And I found this;
Nicotine and other nicotinic agonists have been found to improve performance on attention and memory tasks. Clinical studies using nicotine skin patches have demonstrated the efficacy of nicotine in treating cognitive impairments associated with Alzheimer’s disease, schizophrenia, and attention-deficit/hyperactivity disorder. Experimental animal studies have demonstrated the persistence of nicotine-induced working memory improvement with chronic exposure, in addition to the efficacy of a variety of nicotinic agonists. Mechanistic studies have found that α7 and α4β2 nicotinic receptors in the hippocampus are critical for nicotinic involvement in cognitive function. Clinical and experimental animal studies provide mutually supporting information for the development of novel nicotinic therapies for cognitive dysfunction.
Im sure Mr. Reptilian doesn't like the idea of "irreversible [positive] effects on hippocampal structure, function, learning and memory".
 
Back
Top Bottom